Resources from the same session
Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: an expanded dataset
Presenter: Elena Garralda, Spain
Session: Session XIX: Presentation of Selected Abstracts on GI Cancer
Resources:
Slides
Entrectinib in NTRK fusion-positive gastrointestinal cancers: updated integrated analysis
Presenter: Ignacio Garrido-Laguna, United States
Session: Session XIX: Presentation of Selected Abstracts on GI Cancer
Resources:
Slides
Discussant: SO-31, SO-32, SO-33
Presenter: Juan Manuel O'Connor, Argentina
Session: Session XIX: Presentation of Selected Abstracts on GI Cancer
Resources:
Slides
Impact of BRAF-V600E mutation on immunologic characteristics of the tumor microenvironment (TME) and associated genomic alterations in patients with microsatellite instability-high (MSI-H) or mismatch-repair–deficient (dMMR) colorectal cancer (CRC)
Presenter: Mohamed Salem, United States
Session: Session XIX: Presentation of Selected Abstracts on GI Cancer
Resources:
Slides
T-cell abundance measured by immunoSEQ predicts overall survival in colorectal cancer
Presenter: Stephen Gruber, United States
Session: Session XIX: Presentation of Selected Abstracts on GI Cancer
Resources:
Slides
An immune-related gene expression profile predicts the efficacy of adding atezolizumab to first-line FOLFOXIRI/bevacizumab in metastatic colorectal cancer: a translational analysis of the phase II randomized AtezoTRIBE study
Presenter: Carlotta Antoniotti, Italy
Session: Session XIX: Presentation of Selected Abstracts on GI Cancer
Resources:
Slides
Discussant: LBA SO-34, SO-35, SO-36
Presenter: Pierre Laurent-Puig, France
Session: Session XIX: Presentation of Selected Abstracts on GI Cancer
Resources:
Slides